Chilton Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9
| Closed | -$9.46K | – | 653 |
|
|
2024
Q3 | $9.46K | Sell |
9
-11
| -55% | -$11.6K | ﹤0.01% | 487 |
|
|
2024
Q2 | $21K | Buy |
20
+6
| +43% | +$6.31K | ﹤0.01% | 443 |
|
|
2024
Q1 | $13.5K | Buy |
+14
| New | +$13.5K | ﹤0.01% | 455 |
|
|
2022
Q3 | – | Sell |
-10
| Closed | -$6K | – | 533 |
|
|
2022
Q2 | $6K | Buy |
+10
| New | +$6K | ﹤0.01% | 523 |
|
|
2022
Q1 | – | Sell |
-209
| Closed | -$132K | – | 529 |
|
|
2021
Q4 | $132K | Buy |
+209
| New | +$132K | 0.01% | 250 |
|
|
2016
Q1 | – | Sell |
-380
| Closed | -$206K | – | 171 |
|
|
2015
Q4 | $206K | Buy |
+380
| New | +$206K | 0.02% | 148 |
|